Genetic and pharmacological inhibition of GLUT1 suppressed glycolytic activation in primary mouse lung fibroblasts and myofibroblast activation, and significantly inhibited bleomycin-induced pulmonary fibrosis in vivo. This evidence concerns the gene SLC2A1 and pulmonary fibrosis.